BIOXCEL THERAPEUTICS INC's ticker is and the CUSIP is 09075P905. A total of 4 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62 | -95.0% | 24,900 | -86.6% | 0.00% | -100.0% |
| Q2 2023 | $1,233 | +182.8% | 185,200 | +691.5% | 0.00% | – |
| Q1 2023 | $436 | +213.7% | 23,400 | +260.0% | 0.00% | – |
| Q4 2022 | $139 | -99.9% | 6,500 | -66.8% | 0.00% | – |
| Q3 2022 | $231,000 | +92.5% | 19,600 | +115.4% | 0.00% | – |
| Q2 2022 | $120,000 | +313.8% | 9,100 | +550.0% | 0.00% | – |
| Q1 2022 | $29,000 | -95.2% | 1,400 | -95.3% | 0.00% | -100.0% |
| Q4 2021 | $607,000 | +393.5% | 29,900 | +595.3% | 0.00% | – |
| Q3 2021 | $123,000 | -0.8% | 4,300 | 0.0% | 0.00% | – |
| Q2 2021 | $124,000 | -17.9% | 4,300 | +12185.7% | 0.00% | – |
| Q1 2021 | $151,000 | – | 35 | +34.6% | 0.00% | – |
| Q4 2020 | $0 | – | 26 | -90.8% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 282 | -19.9% | 0.00% | -100.0% |
| Q2 2020 | $1,865,000 | +10870.6% | 352 | +4300.0% | 0.00% | – |
| Q1 2020 | $17,000 | – | 8 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | 158 | $730,000 | 0.03% |
| GROUP ONE TRADING, L.P. | 29,100 | $1,344,000 | 0.00% |
| SIMPLEX TRADING, LLC | 26 | $0 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |